At a glance

Lipocure is a preclinical stage company developing novel liposomal drug candidates for post-surgical pain. LC400 is a novel liposomal hydrogel formulation of Bupivacaine for post-surgical pain. Lipocure’s drug candidates are based on liposomal chemistry that is characterized by the ability to improve pharmacological and pharmacokinetic profiles of known drugs as demonstrated in a large set of robust and comparative assessment system.